NCT00566878View on ClinicalTrials.gov

Pompe Lactation Sub-Registry

CompletedOBSERVATIONAL
Enrollment

2

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

February 9, 2024

Study Completion Date

February 9, 2024

Conditions
Glycogen Storage DiseasePompe Disease
Interventions
BIOLOGICAL

alglucosidase alfa

At least one infusion of alglucosidase alfa post partum

Trial Locations (2)

49503

Grand Rapids

02142

Registry participation is worldwide. Facilities not yet active may enroll upon identification of a patient, Cambridge

All Listed Sponsors
lead

Genzyme, a Sanofi Company

INDUSTRY

NCT00566878 - Pompe Lactation Sub-Registry | Biotech Hunter | Biotech Hunter